CryoLife rises after announcing legal settlements – MSN Money
"CryoLife is now free of its multi-year entanglement with Medafor and we are aware of no other significant legal issues to distract management from executing its growth plan," he wrote. Myers maintained a "buy" rating and price target of $7.50 ...
Subscribe to LegalLaw247.Com Newsletter